• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025
  • Uberon OBO Contribution May 22, 2024

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

NITRIC OXIDE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

TUMOR TIMELESS VASODILATION VEGFA VASCULAR VGF PROTEIN VERO CELLS WOUND HEALING VEINS VIRAL RELEASE FROM HOST CELL THROMBOSIS TREPONEMA DENTICOLA THROMBOCYTOPENIA TMPRSS2 Uberon TYPE 2 DIABETES TISSUE DEVELOPMENT UBIQUITINATION TRANSPORT TROPISM VEGF TRANSLATION TARGET LESION IDENTIFICATION TAU TH17 CELLS TAUOPATHIES TUMOR GROWTH THROMBIN TP53 TROGLITAZONE VIRUS DISEASES TGF-BETA THY-1 ANTIGENS UCHL1 PROTEIN VITAMIN D TUMOR PROGRESSION TRASTUZUMAB TRACHEA X-RAY COMPUTED TOMOGRAPHY THORAX ULCERATIVE COLITIS VASOCONSTRICTION TECFIDERA

© 2025 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}